Periodontal Therapeutics Market Size is evaluated to be USD 1794.95 Million by 2034; Market is driven by Surging Occurrence of Periodontal Diseases

Download Sample

Published Date: February 2025

Periodontal therapeutics market growth is driven by the soaring prevalence of periodontal diseases, including gingivitis and periodontitis, increasing awareness about oral health, Rising geriatric population, technological advancements in dentistry, innovations in treatment modalities, integration of regenerative therapeutics, rising adoption of advance diagnostic tools, personalized periodontal care, and others.

Periodontal Therapeutics Market Segmentation Analysis:

By Source	Gingivitis, Mild to Moderate Periodontitis, Moderate to Advanced Periodontitis
Distribution Channels	Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Periodontal Therapeutics Market Report Highlights:

During 2024, periodontal therapeutics market size was estimated for USD 927.13 Million.
The market is predicted to expand at USD 1794.95 Million and is growing at a CAGR of 7.5%.
In accordance with source, the gingivitis segment is experiencing high growth in the market.
Pursuant to distribution channels, hospital pharmacies have the largest market share for target market.
North America is the largest region in the periodontal therapeutics market.

Periodontal Therapeutics Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Innovations in Treatment Modalities	Limited Awareness and Education for Oral Health	Technological Advancements in Dentistry

Periodontal Therapeutics Market Key Highlights:

In December 2024, a promising study, LumoKaunas2023, is underway in Lithuania to evaluate the Lumoral device's effectiveness in treating severe periodontitis (stages III-IV). Launched in August 2023, this clinical study in Kaunas, Lithuania, aims to investigate whether regular use of Lumoral, a light-activated antibacterial treatment developed by Finnish scientists, can benefit patients with advanced gum disease.
In October 2024, Oral Biolife (OBL), a biotechnology company currently developing a first-of-its-kind dental treatment for both humans and companion animals, announced a new development of data in support of their flagship product: Ambrilux Dental Gel. Recent studies have proven the product to be effective in promoting the regeneration of bone in the furcations of teeth in 3 beagles that were induced with periodontal disease (PD).

Periodontal Therapeutics Market Report Analysis:

List of Systemic Antibiotics Used to Treat Periodontal Patients –

Antibiotic	Dose and Duration	Disease	Side Effects
Amoxicillin Metronidazole	Metronidazole: 250 mg Amoxicillin: 500 mg for 2 years	Stage II periodontitis	One participant experienced nausea and vomiting and one developed candidiasis. Few participants observed light pain or a burning sensation following laser treatment. No side-effects were observed due to administration of antimicrobial agents
Amoxicillin Metronidazole Doxycycline	Metronidazole: 250 mg Amoxicillin: 250 mg Dxycycline: 100 mg for 2 months	Stage III periodontitis	No side effects were reported related to the antibiotic administration
Amoxicillin Clavulanic acid	875 mg each 3 months	Stage I periodontitis	-
Doxycycline Clindamycin Metronidazole	Doxycycline: 200 mg Metronidazole: 500 mg Clindamycin: 150 mg for 2 years	Stage IV periodontitis	-
Azithromycin	500 mg for 6 months	Stage II periodontitis	-
Metronidazole	400 mg thrice a day for 10 days	Moderate to severe periodontitis (Stage III or IV) with Type 2 Diabetes Mellitus	-

Browse ∼50 market data tables and ∼35 figures through ∼180 slides and in-depth TOC on “Periodontal Therapeutics Market, By Type (Gingivitis, Mild to Moderate Periodontitis, and Moderate to Advanced Periodontitis), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region - Trends, Analysis, and Forecast till 2034”

For more insights into the Periodontal Therapeutics Market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/periodontal-therapeutics-market-5471

Competitive Landscape of Periodontal Therapeutics Market:

The key players operating in the periodontal therapeutics market include 3M, Dentsply Sirona, Medtronic, PFIZER INC, Biolase, Bausch Health Companies Inc., Dexcel Pharma, Planmeca, Kaken Pharmaceutical, and Straumann AG.